Treatment of rat adjuvant arthritis with flavonoid (Detralex ®), methotrexate, and their combination

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 798-804

  Rovenský, Jozef ^a   Stančíková, Mária ^a   Rovenská, Emília ^a   Štvrtina, Svetoslav ^b   Štvrtinová, Viera ^b   Švík, Karol ^a  

^a NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^b Faculty of Natural Sciences   (Slovakia)

Author keywords

Adjuvant arthritis; Detralex; Methotrexate; Microcirculation; Purified micronized flavonoid fraction

Indexed keywords

ALBUMIN; DETRALEX; FLAVONOID; METHOTREXATE; MINERAL; NITRITE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHROGRAPHY; BONE DENSITY; COMBINATION CHEMOTHERAPY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; INFLAMMATION; LOW DRUG DOSE; LYMPH VESSEL; MALE; MICROCIRCULATION; MONOTHERAPY; NONHUMAN; PAW EDEMA; PROPHYLAXIS; RAT; SCORING SYSTEM; TREATMENT RESPONSE; VENULE;

RATTUS;

EID: 69949152621     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04618.x     Document Type: Conference Paper

References (32)

1. Lonchampt, M., B. Guardiola, et al. 1989. Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study. Arzneimit-telforschung 39: 882-885.
2. Di Perri, T. & A. Auteri. 1988. Action of S 5682 on the complement system. In vitro and in vivo study. Int. Angiol. 7(Suppl 2): 11-15.
3. Laurent, R., R. Gilly & C. Frileux. 1988. Clinical evaluation of a venotropic drug in man. Int. Angiol. 7(Suppl 2): 39-43.
4. Földi, M. 1999. Atlas of the Lymphatics of the Lower Limbs, pp. s1-80. Les Laboratoires Servier. Paris.
5. Bollinger, A., I. Herrig, et al. 1995. Intravital cap-illaroscopy in patients with chronic venous insufficiency and lymphoedema: relevance to Daflon 500 mg. Int. J. Microcirc. Clin. Exp. 15(Suppl 1): 41-44.
6. Labrid, C. 1995. A lymphatic function of Daflon 500. Int. Angiol. 14(Suppl 1): 36-38.
7. Cotonat, A. & J. Cotonat. 1989. Lymphagogue and pulsatile activities of Daflon 500 on canine thoracic lymph duct. Int. Angiol. 8(Suppl 4): 15-18.
8. Takase, S., F.A. Delano, et al. 1999. Inflammation in chronic venous insufficiency. Is the problem insurmountable? J. Va s c . R e s . 36(Suppl 1): 3-10.
9. Friesenecker, B., A.G. Tsai, et al. 1994. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: in vivo observations in the hamster skin fold. Int. J. Microcirc. 14: 50-55.
10. Jayson, M.I.V. & J.S. Barks. 1971. Oedema in rheumatoid arthritis: changes in the coefficient of capillary filtration. Br. Med. J. 2: 555-557.
11. Jayson, M.I.V., I. Cavill & J.S. Barks. 1971. Lymphatic clearance rates in rheumatoid arthritis. Ann. Rheum. Dis. 30: 638-639.
12. Freemont, A., C.J.P. Jones, et al. 1983. Changes in vascular endothelium related to lymphocyte collections in diseased synovia. Arthritis Rheum. 26: 1427-1443.
13. Schumacher, H.R. & R.C. Kitridou. 1972. Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum. 15: 465-485.
14. Rovenská, E., E. Rovenská & J. Neumüller. 2003. Structure of synovial lymphatic capillaries in rheumatoid arthritis and juvenile idiopathic arthritis. Int. J. Tissue React. 25: 29-38.
15. Xu, H., J. Edwards, et al. 2003. Distribution of lymphatic vessels in normal and arthritic human synovial tissues. Ann. Rheum. Dis. 62: 1227-1229.
16. Rovenská, E., S. Stvrtina, et al. 2005. Conspicuous synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies. Ann. Rheum. Dis. 64: 328-329.
17. Witte, Ch., M.H.Witte & A.E.Dumont. 1984. Patho-physiology of chronic edema, lymphedema, and fi-brosis. In Edema. N.C. Staub & A.E. Taylor, Eds.: 521-542. Raven Press. New York, NY.
18. Cortas, N.K. & N.W. Waking. 1990. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36: 1440-1443.
19. Welles, W.L., J. Silkworth, et al. 1985. Studies on the effect of low dose methotrexate in adjuvant arthritis. J. Rheumatol. 12: 904-906.
20. Connolly, K.M., V.J. Stecher, et al. 1988. Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate. Int. J. Im-munopharmacol. 10: 717-728.
21. Stamler, J.S., D.J. Singel & J. Loscalzo. 1992. Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902.
22. Oyanagui, Y. 1994. Nitric oxide and superoxide radical are involved in both initiation and development of adjuvant arthritis in rats. Life Sci. 54: PL285-289.
23. Cannon, G.W., S.J. Openshaw, et al. 1996. Nitric oxide production during adjuvant-induced and collagen induced arthritis. Arthritis Rheum. 39: 1677-1684.
24. Stefanovic-Racic, M., K. Meyers, et al. 1995. Comparison of the nitric oxide synthase inhibitors methy-larginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J. R h e u m a-tol. 22: 1992-1998.
25. Grabowski, P.S., A.J. England, et al. 1996. Elevated nitric oxide production in rheumatoid arthritis: detection using the fasting urinary nitrate: creatinine ratio. Arthritis Rheum. 39: 643-647.
26. Ueki, Y., S. Miyake, et al. 1996. Increased nitric oxide levels in patients with rheumatoid arthritis. J. R h e u m a-tol. 23: 230-236.
27. Omata, T., Y. Segawa, et al. 1997. Methotrex-ate suppresses nitric oxide production ex vivo in macrophages from rats with adjuvant-induced arthritis. Res. Exp. Med. 197: 81-90.
28. Olszanecki, R., A. Gebska, et al. 2002. Flavonoids and nitric oxide synthase. J. Physiol. Pharmacol. 53: 571-584.
29. Bonnet, J., E. Zerath, et al. 1993. Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: evidence for an early bone formation defect. J. Bone Miner. Res. 8: 659-668.
30. Suzuki, Y., M. Nakagawa, et al. 1997. Short term low dose methotrexate ameliorates abnormal bone metabolism and bone loss in adjuvant induced arthritis. J. Rheumatol. 24: 1890-1895.
31. Kawaguchi, K., H. Maruyama, et al. 2006. Suppression of collagen-induced arthritis by oral administration of the citrus flavonoid hesperidin. Planta Med. 72: 477-479.
32. Shevchuk, S.V., M.A. Stanislavchuk & O.O. Pen-tiuk. 2003. Efficacy and safety of treatment with methotrexate, leflunomide, detralex, and their combination of patients with rheumatoid arthritis. Lik. Sprava. 3-4: 34-41.